Lexaria Bioscience Corp. financial data

Symbol
LEXX, LEXXW on Nasdaq
Location
100 740 Mccurdy Road, Kelowna, British Columbia, Canada
Fiscal year end
August 31
Latest financial report
10-Q - Q2 2025 - Jul 14, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 643 % -79.1%
Quick Ratio 0.96 % -94.4%
Debt-to-equity 16.7 % +246%
Return On Equity -157 % -77.9%
Return On Assets -134 % -59.1%
Operating Margin -1.85K % -63%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 19.6M shares +23.7%
Common Stock, Shares, Outstanding 19.5M shares +23.1%
Entity Public Float 40.6M USD
Common Stock, Value, Issued 19.6K USD +23.7%
Weighted Average Number of Shares Outstanding, Diluted 18.3M shares +32.1%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 616K USD +49.9%
Revenue from Contract with Customer, Excluding Assessed Tax 184K USD +21.6%
Research and Development Expense 7.32M USD +287%
General and Administrative Expense 4.68M USD +47.5%
Operating Income (Loss) -11.4M USD -144%
Nonoperating Income (Expense) -40.2K USD +2.92%
Net Income (Loss) Attributable to Parent -11.4M USD -135%
Earnings Per Share, Diluted 0 USD/shares -61.5%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 4.6M USD
Marketable Securities, Current 33.5K USD -27.6%
Accounts Receivable, after Allowance for Credit Loss, Current 358K USD +71.8%
Inventory, Net 0 USD -100%
Assets, Current 5.81M USD -36.1%
Property, Plant and Equipment, Net 240K USD +9.51%
Operating Lease, Right-of-Use Asset 157K USD +9.37%
Assets 6.74M USD -32.7%
Liabilities, Current 1.49M USD +854%
Operating Lease, Liability, Noncurrent 86.7K USD
Liabilities 1.57M USD +480%
Accumulated Other Comprehensive Income (Loss), Net of Tax -81.1K USD -271%
Retained Earnings (Accumulated Deficit) -60.8M USD -23.1%
Stockholders' Equity Attributable to Parent 5.55M USD -45.2%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest 5.17M USD -47%
Liabilities and Equity 6.74M USD -32.7%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -2.73M USD -131%
Net Cash Provided by (Used in) Financing Activities 4.35M USD +139%
Net Cash Provided by (Used in) Investing Activities -37.8K USD +5.55%
Common Stock, Shares Authorized 220M shares 0%
Common Stock, Shares, Issued 19.6M shares +23.7%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 1.58M USD +162%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 4.59M USD -45.7%
Deferred Tax Assets, Valuation Allowance 10.7M USD +12%
Deferred Tax Assets, Gross 10.7M USD +12%
Operating Lease, Liability 117K USD -18.2%
Payments to Acquire Property, Plant, and Equipment 24.6K USD
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -11.5M USD -135%
Lessee, Operating Lease, Liability, to be Paid 132K USD -21%
Property, Plant and Equipment, Gross 772K USD
Operating Lease, Liability, Current 29.9K USD
Lessee, Operating Lease, Liability, to be Paid, Year Two 38.6K USD +4.17%
Lessee, Operating Lease, Liability, to be Paid, Year One 37.3K USD +317%
Operating Lease, Weighted Average Discount Rate, Percent 0.07 pure 0%
Lessee, Operating Lease, Liability, to be Paid, Year Three 38.9K USD +4.17%
Lessee, Operating Lease, Liability, to be Paid, Year Four 8.1K USD -79%
Operating Lease, Payments 8.96K USD -80%
Additional Paid in Capital 66.4M USD +11.6%
Depreciation, Depletion and Amortization 8.73K USD
Deferred Tax Assets, Net of Valuation Allowance 0 USD
Share-based Payment Arrangement, Expense 99.4K USD +84.3%